Insider filing · LGND
Jason Aryeh
Director
profile →
Ligand Pharmaceuticals Incorporated
LGND · Healthcare · 37 filings in 24 months
ticker →
Jason Aryeh sold $1.7M of Ligand Pharmaceuticals Incorporated (LGND)
Executed Sep 23 2025, disclosed Sep 24 2025, 1 day later.
Value, as filed
$1.7M
10,000 sh across 3 lots
Executed
Sep 23 2025
the trade date, as filed
Disclosed
Sep 24 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JAJason Aryeh (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ligand Pharmaceuticals Incorporated (LGND). The largest single filing was $1.2M of LGND (5,000 sh across 2 lots, as filed), executed Jun 10.
The name
LGNDHealthcare · Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jason Aryeh in LGND
LGNDSALE
Ligand Pharmaceuticals Incorporated
$612K1,909 sh across 2 lots
Exec Oct 30
Filed Nov 3 · 7:39 PM ET LGNDSALE Ligand Pharmaceuticals Incorporated $1.2M
5,000 sh across 2 lots
Exec Jun 10
Filed Jun 12 · 5:30 PM ET